CN101926899A - Health-care medicament for hyperlipemia and preparation method thereof - Google Patents
Health-care medicament for hyperlipemia and preparation method thereof Download PDFInfo
- Publication number
- CN101926899A CN101926899A CN2010102737283A CN201010273728A CN101926899A CN 101926899 A CN101926899 A CN 101926899A CN 2010102737283 A CN2010102737283 A CN 2010102737283A CN 201010273728 A CN201010273728 A CN 201010273728A CN 101926899 A CN101926899 A CN 101926899A
- Authority
- CN
- China
- Prior art keywords
- medicament
- parts
- preparation
- hyperlipemia
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 201000005577 familial hyperlipidemia Diseases 0.000 title abstract 5
- 239000000284 extract Substances 0.000 claims abstract description 15
- 239000002775 capsule Substances 0.000 claims abstract description 8
- 229920002472 Starch Polymers 0.000 claims abstract description 7
- 235000019698 starch Nutrition 0.000 claims abstract description 7
- 239000008107 starch Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 15
- 230000036541 health Effects 0.000 claims description 14
- 241000237636 Pheretima Species 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 239000012567 medical material Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 238000005550 wet granulation Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 8
- 239000000203 mixture Substances 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 5
- 241001465754 Metazoa Species 0.000 abstract description 5
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract description 3
- 238000007670 refining Methods 0.000 abstract description 3
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract description 2
- 240000000171 Crataegus monogyna Species 0.000 abstract description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract description 2
- 241000361919 Metaphire sieboldi Species 0.000 abstract description 2
- 208000016097 disease of metabolism Diseases 0.000 abstract description 2
- 208000030159 metabolic disease Diseases 0.000 abstract description 2
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000009982 effect on human Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 18
- 235000012000 cholesterol Nutrition 0.000 description 9
- 235000019197 fats Nutrition 0.000 description 9
- 239000003172 expectorant agent Substances 0.000 description 7
- 230000003419 expectorant effect Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- HNOSJVWYGXOFRP-UNPOXIGHSA-N (5r,8s,9s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-17-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1CC[C@@]1(C)[C@H]2[C@@H](O)CC2=C([C@@H](C[C@H](O)[C@@H](O)C(C)(C)O)C)CC[C@@]21C HNOSJVWYGXOFRP-UNPOXIGHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HNOSJVWYGXOFRP-UHFFFAOYSA-N Alisol A Natural products CC12CCC(=O)C(C)(C)C1CCC1(C)C2C(O)CC2=C(C(CC(O)C(O)C(C)(C)O)C)CCC21C HNOSJVWYGXOFRP-UHFFFAOYSA-N 0.000 description 1
- -1 Alisol A Chemical class 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- SYKWLIJQEHRDNH-KRPIADGTSA-N glutaryl-coa Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSC(=O)CCCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 SYKWLIJQEHRDNH-KRPIADGTSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 150000002966 pentacyclic triterpenoids Chemical class 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a health-care medicament for hyperlipemia and a preparation method thereof. The hyperlipemia is a common and frequently-occurring metabolic disease. The conventional medicaments for treating the hyperlipemia are mostly single medicinal components; and the medicinal components have wide varieties, and have side effect after taken for long. The invention provides the health-care medicament for the hyperlipemia and the preparation method thereof. The medicament consists of the following raw materials in part by weight: 280 to 320 parts of hawthorn fruit, 280 to 320 parts of tuber fleeceflower root, 180 to 220 parts of oriental waterplantain rhizome, 80 to 120 parts of earthworm and 80 to 120 parts of lotus leaf. The preparation method comprises the following steps of: preparing extracts, adding starch, granulating the mixture by a wet method and preparing the mixture into capsules. The prescription of the medicament is rational and scientific; the medicament is prepared by refining by a scientific method; and the compositional plants and animals of the medicament are mostly the components functioning as both food and the medicament, so the medicament does not have any toxic or side effect on human bodies, has remarkable effect and is easy to use for long.
Description
Technical field
The present invention relates to a kind of health medicine, specifically is a kind of health medicine that is used for hyperlipidemia and preparation method thereof.
Background technology
Improving constantly owing to the material life level in the modern society, the change of dietary structure, people's diet is careless, preference for fat and sweet food, cause figure's obesity in the middle-aged and elderly people, blood fat higher person increase suddenly, and modern medicine study is thought: hyperlipidemia is a kind of common and multiple metabolic disease, mainly shows as the normal level that is higher than of one or more compositions in the blood plasma lipide.Blood fat is higher to be the principal element that causes the atherosclerotic cardiovascular and cerebrovascular disease.The tradition traditional Chinese medical science thinks that the generation of hyperlipidemia is relevant with composite factors such as age, diet, body constitution and heredity, though it is sick intricate, its basic pathology becomes deficiency in origin and excess in superficiality, promptly kidney,liver,spleen deficient this, the expectorant stasis of blood is for marking.The rule of treatment should be blood circulation promoting and blood stasis dispelling, resolving turbidity and eliminating dampness, and nourishing the liver and kidney, dredging the meridian is main.In the medicine of present treatment hyperlipidemia, be single medicinal ingredient all mostly, ingredient is of a great variety, and is long-term edible, has side effect.
Summary of the invention
The object of the present invention is to provide a kind of health medicine that is used for hyperlipidemia and preparation method thereof, its reasonable recipe science processes through scientific method is refining, and forms animals and plants and mostly be the food and medicament dual-purpose composition, without any side effects to the human body thing, and effect obviously is easy to life-time service.
For achieving the above object, the technical solution used in the present invention is: a kind of health medicine that is used for hyperlipidemia is characterized in that: the raw material by following weight portion is formed,
Fructus Crataegi 280-320 part, Radix Polygoni Multiflori 280-320 part, Rhizoma Alismatis 180-220 part, Pheretima 80-120 part, Folium Nelumbinis 80-120 part.
The above-mentioned health medicine that is used for hyperlipidemia is made up of the raw material of following weight portion,
300 parts of Fructus Crataegis, 300 parts of Radix Polygoni Multiflori, 200 parts of Rhizoma Alismatis, 100 parts of Pheretimas, 100 parts on Folium Nelumbinis.
The preparation method of above-mentioned health medicine is characterized in that, comprises the steps:
One, preparation extract
Get above-mentioned Six-element bulk drugs and pulverize, make fine powder, the fine powder particle diameter is 5-10 μ m; Adopt decocting to boil three times the gained fine powder, each two hours, filter; Filtrate is condensed into medical material: medicinal liquid is the ratio of 2:1; Adding volume fraction in the medicinal liquid of gained is 95% ethanol, and making concentration of alcohol is 60%, precipitates after 2 days to filter once more; Filtering filtrate concentrating made dry extract;
Two, preparation capsule
Extract dry extract at first step adds the starch wet granulation, and aeration-drying below 80 ℃ becomes capsule with the dried particles fill.
The present invention has following advantage and effect with respect to prior art:
1, according to the combination of modern medical theory and Chinese medicine theory, after the higher pathogeny of analysis-by-synthesis human body blood fat, at body blood fat height, select animals and plants Chinese medicine for use, scientific composition, refining forming, and animals and plants mostly are the food and medicament dual-purpose composition, treatment and health care combine, and human body is had no side effect, and are suitable for long-term edible;
2, adopt superfine communication technique, the cell wall rupture of the most cells of medical material, effective ingredient need directly not contact with medicine-feeding part through the cell wall barrier in the cell, medicated powder very easily is adsorbed on the small bowel, absorbed by small bowel, the stripping and the utilization rate of effective ingredient can effectively be provided, strengthen the quality of preparation.
The specific embodiment
Motherland's medical science thinks, it is the turbid resistance network of expectorant, qi depression to blood stasis that hyperlipidemia forms pathogenesis, and the cavalryman is because of being more common in food delicious food savoury, dysfunction of the spleen in transportation, wet poly-for expectorant, expectorant is turbid does not change, or the liver failing to maintain the normal flow of QI, or insufficiency of stomach is warm unable, gives birth in expectorant is turbid, finally in arteries and veins, qi depression to blood stasis forms.The present invention is made up of Fructus Crataegi, Radix Polygoni Multiflori, Rhizoma Alismatis, Pheretima, Folium Nelumbinis Six-element Chinese medicine, and wherein, the Pheretima nature and flavor are salty-cold, return liver spleen urinary bladder channel, have clearing heat for calming endogenous wind, the collateral dredging diuresis of relievining asthma, be monarch drug, and Pheretima contains abundant earthworm kinases, have good thrombolytic effect; Hawthorn digesting eliminate indigestion blood circulation promoting and blood stasis dispelling is ministerial drug, cooperates monarch drug to strengthen the function of blood circulation promoting and blood stasis dispelling, Radix Polygoni Multiflori is returned liver heart kidney channel, have liver and kidney tonifying, the effect of nourishing blood to expel wind, loosening bowel to relieve constipation is with the public effect of Rhizoma Alismatis clearing away heat and promoting diuresis eliminating dampness by diuresis, to avoid wet gathering is that expectorant is turbid, the soldier is in blood vessels, and it is an adjuvant drug, is amusing with the Folium Nelumbinis cooling blood for hemostasis the lucid yang sending up that light weight is up, be apt to reach the heart and brain position, be messenger drug.Therefore, monarch of the present invention, minister, help, make essence to delay, compatibility Radix Polygoni Multiflori, Rhizoma Alismatis are that turbid damp is discharged from defecation among Pheretima, Fructus Crataegi blood circulation promoting and blood stasis dispelling, a surname's numbness collateral dredging, be difficult to hinder in arteries and veins, join Folium Nelumbinis with Fructus Crataegi again, spleen invigorating is amusing in the time of blood circulation promoting and blood stasis dispelling, is the strong fortune of spleen, can not gather the wet expectorant that is, its prescription compatibility flavour of a drug are less, treatment must aim at the pathogenesis of disease, treating both the principal and secondary aspects of a disease.
Six-element herbal nature composition of the present invention is as follows:
Radix Polygoni Multiflori contains anthraquinone component, be mainly emodin, chrysophanol etc., contain abundant starch, crude fat, lecithin etc. in addition, the modern pharmacology experiment shows: Radix Polygoni Multiflori is to high fat patient's in old age triglyceride, cholesterol and high-density protein cholesterol all have clear improvement, and have the cholesterol of minimizing synthetic or conversion of acceleration cholesterol and excretory effect.
Fructus Crataegi always mainly contains the Fructus Crataegi acids, flavonoid, glycoside and lactone composition, pharmacological evaluation shows, Cavia porcellus hepatocyte microsome and the synthetic speed limit of mucous membrane of small intestine cholesterol after the Fructus Crataegi water decoction serve on for 3 weeks, enzyme hydroxyl first glutaryl CoA reductase active component descends 70% and 67% respectively, in addition Fructus Crataegi total flavones can diastole coronary vasodilator, 15% and 30% hawthorn extract has tangible effect for reducing fat to the young rat of breast.
Mainly contain pentacyclic triterpenoid and part unsaturated fatty acids such as Alisol A, B in the Rhizoma Alismatis, pharmacological evaluation shows: the Rhizoma Alismatis water decoction has therapeutical effect to the fatty liver that the low proteic diet of rat causes, can alleviate the hyperlipidemia that the oral Oleum Gossypii semen of rat causes, and can slightly reduce the atherosclerotic cholesterolemia of rabbit experiment, relax the development of pathological changes, the absorption of its effect for reducing fat and the exogenous cholesterol of its interference is relevant with the metabolism of endogenous cholesterol.
Folium Nelumbinis is food and medicament dual-purpose plant commonly used, modern study finds that it contains abundant lotus alkali, organic acids such as multiple biological alkali such as lotus alkali and quercetin, pharmacological evaluation shows that the Folium Nelumbinis water decoction has tangible decline effect to triglyceride, cholesterol, it can impel unnecessary lipid drainage in the human body, the draw up absorption of exogenous lipid promotes the metabolism of cholesterol, thereby reaches the effect of blood fat reducing.
Pheretima is a kind of animal of food and medicament dual-purpose commonly used, wherein contain essential several amino acids, protein and unsaturated fatty acid in the human body, and contain active ingredient Pheretima enzyme of blood circulation promoting and blood stasis dispelling etc., it has the effect that increases human bloodstream amount, microcirculation improvement and share with Radix Polygoni Multiflori and can strengthen getting rid of lipide component from human body blood the effect of reduction whole blood apparent viscosity.
Embodiment 1
A kind of health medicine that is used for hyperlipidemia has the preparation of following method: at first get Fructus Crataegi 280g, Radix Polygoni Multiflori 320 g, Rhizoma Alismatis 180 g, Pheretima 120 g, Folium Nelumbinis 80 g pulverize, and make the fine powder that particle diameter is 5-10 μ m; Adopt decocting to boil three times the gained fine powder, each two hours, filter; Filtrate is condensed into medical material: medicinal liquid is the ratio of 2:1; Add 95% ethanol in the medicinal liquid of gained, making concentration of alcohol is 60%, precipitates after 2 days to filter once more; Filtering filtrate concentrating made dry extract; Dry extract is added the starch wet granulation, and aeration-drying below 80 ℃ becomes capsule with the dried particles fill.
Embodiment 2
A kind of health medicine that is used for hyperlipidemia has the preparation of following method: get Fructus Crataegi 302g, Radix Polygoni Multiflori 280 g, Rhizoma Alismatis 220 g, Pheretima 80 g, Folium Nelumbinis 120 g pulverize, and make the fine powder that particle diameter is 5-10 μ m; Adopt decocting to boil three times the gained fine powder, each two hours, filter; Filtrate is condensed into medical material: medicinal liquid is the ratio of 2:1; Adding volume fraction and be 95% ethanol in the medicinal liquid of gained, to make concentration of alcohol be 60%, precipitates after 2 days and filter once more; Filtering filtrate concentrating made dry extract; Dry extract is added the starch wet granulation, and aeration-drying below 80 ℃ becomes capsule with the dried particles fill.
Embodiment 3
A kind of health medicine that is used for hyperlipidemia has the preparation of following method: get Fructus Crataegi 300g, Radix Polygoni Multiflori 300 g, Rhizoma Alismatis 200 g, Pheretima 100 g, Folium Nelumbinis 100 g pulverize, and make the fine powder that particle diameter is 5-10 μ m; Adopt decocting to boil three times the gained fine powder, each two hours, filter; Filtrate is condensed into medical material: medicinal liquid is the ratio of 2:1; Adding volume fraction in the medicinal liquid of gained is 95% ethanol, and making concentration of alcohol is 60%, precipitates after 2 days to filter once more; Filtering filtrate concentrating made dry extract; Dry extract is added the starch wet granulation, and aeration-drying below 80 ℃ becomes capsule with the dried particles fill.
Best in the foregoing description with embodiment 3 effects.
Claims (3)
1. health medicine that is used for hyperlipidemia, it is characterized in that: the raw material by following weight portion is formed,
Fructus Crataegi 280-320 part Radix Polygoni Multiflori 280-320 part Rhizoma Alismatis 180-220 part
Pheretima 80-120 part Folium Nelumbinis 80-120 part.
2. a kind of health medicine that is used for hyperlipidemia according to claim 1, it is characterized in that: the raw material by following weight portion is formed,
100 parts on 100 parts of Folium Nelumbinis of 200 parts of Pheretimas of 300 portions of Rhizoma Alismatis of 300 parts of Radix Polygoni Multiflori of Fructus Crataegi.
3. the preparation method of claim 1 or 2 described health medicines is characterized in that, comprises the steps:
One, preparation extract
Get above-mentioned Six-element bulk drugs and pulverize, make fine powder, the fine powder particle diameter is 5-10 μ m; Adopt decocting to boil three times the gained fine powder, each two hours, filter; Filtrate is condensed into medical material: medicinal liquid is the ratio of 2:1; Adding volume fraction in the medicinal liquid of gained is 95% ethanol, and making concentration of alcohol is 60%, precipitates after 2 days to filter once more; Filtering filtrate concentrating made dry extract;
Two, preparation capsule
Extract dry extract at first step adds the starch wet granulation, and aeration-drying below 80 ℃ becomes capsule with the dried particles fill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102737283A CN101926899B (en) | 2010-09-07 | 2010-09-07 | Health-care medicament for hyperlipemia and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102737283A CN101926899B (en) | 2010-09-07 | 2010-09-07 | Health-care medicament for hyperlipemia and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101926899A true CN101926899A (en) | 2010-12-29 |
| CN101926899B CN101926899B (en) | 2011-10-26 |
Family
ID=43366503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102737283A Active CN101926899B (en) | 2010-09-07 | 2010-09-07 | Health-care medicament for hyperlipemia and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101926899B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104857424A (en) * | 2015-04-27 | 2015-08-26 | 张斌 | Medicine for treating thick blood lipid and preparation method thereof |
| CN106474219A (en) * | 2016-11-11 | 2017-03-08 | 天津蚓福生物科技开发有限公司 | Blood fat reducing pressed candy |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02215725A (en) * | 1989-02-15 | 1990-08-28 | Eimei:Kk | Anti-hyperlipidemia agent |
| CN1147952A (en) * | 1996-09-09 | 1997-04-23 | 王全江 | Tea for preventing and curing coronary heart disease and method for preparing same |
| CN1660207A (en) * | 2004-12-29 | 2005-08-31 | 韦平生 | Preparation of health care for reducing blood fat and cholesterol, and producing method |
| JP2009249362A (en) * | 2008-04-09 | 2009-10-29 | Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 | Method for producing detoxified dried earthworm powder |
-
2010
- 2010-09-07 CN CN2010102737283A patent/CN101926899B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02215725A (en) * | 1989-02-15 | 1990-08-28 | Eimei:Kk | Anti-hyperlipidemia agent |
| CN1147952A (en) * | 1996-09-09 | 1997-04-23 | 王全江 | Tea for preventing and curing coronary heart disease and method for preparing same |
| CN1660207A (en) * | 2004-12-29 | 2005-08-31 | 韦平生 | Preparation of health care for reducing blood fat and cholesterol, and producing method |
| JP2009249362A (en) * | 2008-04-09 | 2009-10-29 | Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 | Method for producing detoxified dried earthworm powder |
Non-Patent Citations (1)
| Title |
|---|
| 《山西中医》 19961230 杨林 高脂血症的成因及辨证治疗3法 , 第06期 2 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104857424A (en) * | 2015-04-27 | 2015-08-26 | 张斌 | Medicine for treating thick blood lipid and preparation method thereof |
| CN106474219A (en) * | 2016-11-11 | 2017-03-08 | 天津蚓福生物科技开发有限公司 | Blood fat reducing pressed candy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101926899B (en) | 2011-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102160573B (en) | Milk shake for replacing meal and preparation method thereof | |
| CN103719498B (en) | A kind of Siberian solomonseal rhizome health-care tea improving immunity and preparation method thereof | |
| CN106215032A (en) | A kind of bowel relieving weight reducing compound preparation and preparation method thereof | |
| CN103168883A (en) | Pathogenic microorganism preventing antiviral tea beverage granules capable of boosting immunity and preparation method thereof | |
| CN101607051B (en) | Traditional Chinese medicine composition for losing weight and preparation method thereof | |
| CN101766296A (en) | Functional food for weight loosing and preparation process thereof | |
| CN103230486B (en) | Traditional Chinese medicine composition, preparation method thereof, and application thereof in preparing medicines used for treating fatty liver | |
| CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
| CN107836619A (en) | A kind of beautiful millettia root solid beverage with strengthen immunity and antifatigue effect and preparation method thereof | |
| CN101926899B (en) | Health-care medicament for hyperlipemia and preparation method thereof | |
| CN105267906A (en) | Compound chocolate Chinese herbal composition for treating and improving menstrual syndrome of females | |
| CN103202956A (en) | Antihypertensive life-preserving health-care medicinal liquor | |
| CN102823700A (en) | Preparation method of compound poria cocos and black garlic filled chocolate | |
| CN106070783A (en) | A kind of production technology of Semen Coicis damp eliminating tea | |
| CN102526639B (en) | Chinese medicinal composition for treating hyperlipidemia and preparation method thereof | |
| CN103960415A (en) | Weight-losing health herbal tea and preparation method thereof | |
| CN103550505A (en) | Traditional Chinese medicine preparation for treating qi-yin deficiency type diabetes | |
| CN103623120A (en) | Lozenge for clearing heat from throat and benefiting throat | |
| CN107333945A (en) | A kind of sweet wormwood herbal tea and preparation method thereof | |
| CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
| CN106177712A (en) | A kind of magnificent Bulbus Allii bean treating cardiovascular and cerebrovascular disease and preparation method thereof | |
| CN101433577A (en) | Mung bean sobering-up agent and preparation method thereof | |
| CN106578185A (en) | Jiangjunhong blood fat lowering tea and preparation method thereof | |
| CN104056234A (en) | Drug for dispelling alcohol effect and preparing method thereof | |
| CN109758541A (en) | A kind of electuary and preparation method thereof improving children's taste |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170526 Address after: Qin Yue Lu 712000 Xianyang city of Shaanxi Province Qin District No. 9 Patentee after: Shaanxi Jun Dekang Pharmaceutical Co. Ltd. Address before: The road high tech Zone Technology 710065 Shaanxi city of Xi'an province No. 30 B block 701 Cheshire force Patentee before: Xu Yang |